New Delhi [India], May 5: KRM Ayurveda Limited (NSE: KRMAYURVED), one of India’s emerging integrated Ayurvedic healthcare platforms, announced its audited financial results for the year ended March 31, 2026. Financial Performance Highlights H2 FY26 vs H2 FY25 Particulars (₹ In Lakhs) H2 FY26 H2 FY25 YoY Growth Revenue from operations 5, 333. 36 4, 084. 19 30. 59% EBITDA



